Using Vibroacoustic Therapy in a Patient With Co-infection and COVID-19

Astana Medical University

Status

Completed

Conditions

SARS CoV 2 Infection

Treatments

Device: vibroacoustic therapy

Study type

Observational

Funder types

Other

Identifiers

NCT05188482

MUA

Details and patient eligibility

About

This article describes a case of successful treatment of a 59-year-old man with sepsis as a result of periprosthetic infection against the background of severe SARS-CoV-2-19, who was hospitalized for 59 days, 57 of which were in the intensive care unit. Vibroacoustic pulmonary therapy, the concept of noninvasive ventilation, syndrome therapy, combination antibiotic therapy taking into account the pathogen and antibiotic sensitivity were used in the treatment.

Full description

During the pandemic caused by SARS-CoV-2-19, the whole world faced difficulties. Nevertheless, surgeons had to perform surgical treatment for patients who needed immediate help with a confirmed coronavirus infection [1, 2, 3].

Periprosthetic joint infection is a severe and undesirable consequence after arthroplasty [4, 5]. Patients with coronavirus infection and bacterial infection correlate with an unfavorable outcome [6, 7, 8] The effect of vibroacoustic therapy in the treatment of various conditions has not been sufficiently studied [9, 10]. This clinical case describes the complex therapy of a patient with a periprosthetic infection on the background of SARS-CoV-2 using a vibroacoustic pulmonary device.

Enrollment

1 patient

Sex

Male

Ages

59 to 59 years old

Volunteers

No Healthy Volunteers

Inclusion criteria